Heart Disease and Regeneration: Insights from Development
joint with Cell Biology of the Heart: Beyond the Myocyte-Centric View
Organizer(s): Vincent M. Christoffels, James F. Martin and Deborah L. YelonDate: March 01 - 06, 2015
Location: Copper Mountain Resort, Copper Mountain, CO, USA
Heart disease is the leading cause of death worldwide, affecting both children and adults. It is now clear that congenital heart defects result from disorders in developmental mechanisms of differentiation and morphogenesis and that these disorders are often the consequence of genetic variation. Moreover, there is increasing evidence that these same developmental mechanisms and genetic variations contribute to heart disease throughout life, and this understanding could be leveraged for regenerative therapies. This meeting will highlight new concepts in cardiovascular development, regeneration and repair and will emphasize common molecular mechanisms with therapeutic potential for cardiovascular regeneration. Sessions on the regulatory mechanisms of cardiac development, lineage specification, stem cell differentiation and proliferation will integrate current insights into the molecular mechanisms connecting patterning, morphogenesis, homeostasis and disease. Emerging technologies for genome editing and imaging will be discussed with the aim of facilitating new research directions and translational approaches. Overall, the goal of this meeting is to bring together researchers with expertise in cardiac development, molecular biology, stem cell biology, genetics and epigenetics to facilitate our understanding of heart development and homeostasis and to explore scientific directions and therapeutic approaches for the treatment of heart disease in children and adults.
Scholarship Deadline: November 4 2014
Discounted Abstract Deadline: November 4 2014
Abstract Deadline: December 3 2014
Discounted Registration Deadline: January 6 2015
We gratefully acknowledge additional support for this conference from:
American Heart Association's Councils on Basic CV Sciences, and CV Disease in the Young
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Cellular Dynamics International
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL126262-01
Funding for this conference was made possible (in part) by 1R13HL126262-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.